NasdaqHealth CarePharmaceutical PreparationsNEW YORK, United States

Immunic, Inc. IMUX

Ask your AI

The reported share count looks too low next to the company’s average share countCIK 1280776

Insider trades, 12 mo

—

No open-market trades

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

32.7% of shares · 13 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Immunic, Inc.'s latest quarterly report, compared with the one before.

Filed Nov 13, 2026 · Quarter ended Sep 30, 2026

AI No AI summary for this 10-Q: management's discussion could not be compared, and the other sections did not change.

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: risk factors and legal proceedings.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Immunic, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Jun 13, 2025. Insiders have two business days to file.

Recent insider trades

Jason Tardio President and COO	Jun 5, 2025 Form 4/A ↗	Buy	+$9,884 12,512 sh @ $0.79	-29.9%
Daniel Vitt CEO and Director, Director	Jun 4, 2025 Form 4/A ↗	Buy	+$11.6K 15,000 sh @ $0.77	-29.6%
Duane Nash Executive Chairman, Director	Jun 13, 2025 Form 4 ↗	Buy	+$16.6K 20,000 sh @ $0.83	-32.9%
Joerg Neermann Director	Jun 5, 2025 Form 4 ↗	Buy	+$22.8K 30,000 sh @ $0.76	-29.9%
Joerg Neermann Director	Jun 4, 2025 Form 4 ↗	Buy	+$53.9K 70,000 sh @ $0.77	-29.6%

All IMUX insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

5.19M shares

49 funds report IMUX. Values checked against market prices.

Funds own 64% of shares (Q2 2026)

55 funds hold the stock.

Q3 2026: 33% · 5,560 of ~8,900 funds reported so far

Q1 20260.7%
Q2 202664%
Q3 2026 (so far)33%

Q3 2026. 17 new, 13 added to, 7 trimmed, 23 exited since Q2 2026.

Top 13F holders
#
1	Aberdeen Group plc 13F ↗	1.09M	$10.1M	+32.3%
2	Morgan Stanley 13F ↗	704,244	$6.5M	+2865.5%
3	Laurion Capital Management LP 13F ↗	610,326	$5.7M	unchanged
4	Vanguard Capital Management LLC 13F ↗	571,561	$5.3M	unchanged
5	Marshall Wace, LLP 13F ↗	359,319	$3.3M	+242.8%
6	Nantahala Capital Management, LLC 13F ↗	250,646	$2.3M	-50.0%
7	Propel Bio Management, LLC 13F ↗	236,734	$2.2M	-27.2%
8	Jane Street Group, LLC 13F ↗	214,163	$2.0M	+138.8%
9	UBS Group AG 13F ↗	183,629	$1.7M	+4.5%
10	Geode Capital Management, LLC 13F ↗	172,142	$1.6M	+0.9%

Download CSV Every fund that holds IMUX, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Immunic, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Immunic, Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report, adjusted for splits

Funds holding the stock by quarter

Q1 2026	3	—	95,297	$1.1M
Q2 2026	55	+52	8.69M	$133.6M
Q3 2026	49	-6	5.19M	$48.3M

Each point is a quarter-end, from Q1 2026 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (4525EP200). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q1 2026) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits (1-for-10 on Apr 27, 2026): reports from before a split are multiplied by its ratio, so every quarter is on the share count of Q3 2026.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes24 in 12 mo 8-K events4 in 90 days Patents3 patents granted Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials3 active Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: IMMUNIC, INC.
Address: 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States 10036
Phone: (332) 255-9818
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: DE
Listed as: IMUX (Nasdaq)
Former names: VITAL THERAPIES INC (until 2019)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$7.52−$0.27 (−3.47%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $6.66 · High $8.12Nov 13, 2026

Aug 13, 2026Low $6.66 · High $16.90Nov 13, 2026

Nov 13, 2025Low $5.10 · High $16.90Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. The stock split 1-for-10 on Apr 27, 2026; earlier prices are shown divided by the split ratio. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.